Impact of concomitant cardiovascular medications on overall survival in patients with liver cirrhosis

Li, M., Itzel, T., Montagut, N. E., Falconer, T., Daza, J., Park, J., Cheong, J. Y., Park, R. W., Wiest, I., Ebert, M. P., Hripcsak, G., & Teufel, A. (2023). Impact of concomitant cardiovascular medications on overall survival in patients with liver cirrhosis. Scandinavian Journal of Gastroenterology, 58(12), 1505–1513. https://doi.org/10.1080/00365521.2023.2239974
Authors:
Moying Li
Timo Itzel
Nathally Espinosa Montagut
Thomas Falconer
Jimmy Daza
Jimyung Park
Jae Youn Cheong
Rae Woong Park
Isabella Wiest
Matthias Philip Ebert
George Hripcsak
Andreas Teufel
Affiliated Authors:
Thomas Falconer
George Hripcsak
Columbia Affiliation:
Subjects:
Liver Cirrhosis (MeSH)
Losartan (MeSH)
Author Keywords:
liver cirrhosis
cardiovascular co-medication
comorbidities
multidisciplinary management
overall survival
elink
Publication Type:
Article
Unique ID:
10.1080/00365521.2023.2239974
PMID:
37608699
DOI:
10.1080/00365521.2023.2239974
Journal:
Scandinavian Journal of Gastroenterology
Publication Date:
Data Source:
PubMed
Source Link:
View PubMed Record

Record Created: